Gestational Diabetes Initiative
Donor: Novo Nordisk
Background: There is increased understanding of the negative impact that diabetes has on people’s lives, life chances and overall wellbeing. There is strong evidence to indicate that over 76 million women with diabetes or pre-diabetes (IGT) are in the reproductive age and at risk of having their pregnancy complicated by hyperglycaemia. A comprehensive resource setting out evidence-based guidance on screening, diagnosing and providing care for women with gestational diabetes mellitus (GDM) remains unavailable to key healthcare professionals.
To disseminate and implement evidence-based standards of care protocols on caring for women with gestational diabetes in collaboration with obstetricians and gynecologists and other key healthcare professionals and workers.